PDB61 HEALTH CARE COSTS AND UTILIZATION ASSOCIATED WITH TREATMENT MODIFICATION IN TYPE-2 DIABETES MELLITUS (T2DM) PATIENTS TAKING ORAL ANTI-DIABETIC DRUGS (OADS)

May 1, 2009, 00:00 AM
10.1016/S1098-3015(10)73604-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)73604-4/fulltext
Section Title :
Section Order : 51
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73604-4&doi=10.1016/S1098-3015(10)73604-4
HEOR Topics :
Tags :
Regions :